NO932289L - 2'-deoksy-2',2'-difluor(4-substituerte pyrimidin)nukleosider med antiviralog anticanceraktivitet og mellomprodukter - Google Patents
2'-deoksy-2',2'-difluor(4-substituerte pyrimidin)nukleosider med antiviralog anticanceraktivitet og mellomprodukterInfo
- Publication number
- NO932289L NO932289L NO932289A NO932289A NO932289L NO 932289 L NO932289 L NO 932289L NO 932289 A NO932289 A NO 932289A NO 932289 A NO932289 A NO 932289A NO 932289 L NO932289 L NO 932289L
- Authority
- NO
- Norway
- Prior art keywords
- deoxy
- difluoro
- intermediates
- nucleosides
- anticancer activity
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
Det blir beskrevet forbindelser med formel (I hvor Z er valgt fra gruppen bestående av: 2-deoksy-2',2'-difluor (4-substltuerte) pyrimldin- nukleosidene har antlcanser- og antlviral aktivitet. Det er dessuten beskrevet mellomprodukter i fremstil- lingen av disse nukleosidene.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US90231492A | 1992-06-22 | 1992-06-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
NO932289D0 NO932289D0 (no) | 1993-06-21 |
NO932289L true NO932289L (no) | 1993-12-23 |
Family
ID=25415673
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO932289A NO932289L (no) | 1992-06-22 | 1993-06-21 | 2'-deoksy-2',2'-difluor(4-substituerte pyrimidin)nukleosider med antiviralog anticanceraktivitet og mellomprodukter |
Country Status (21)
Country | Link |
---|---|
US (1) | US5430026A (no) |
EP (1) | EP0576230B1 (no) |
JP (1) | JPH0656876A (no) |
KR (1) | KR940005657A (no) |
CN (1) | CN1084177A (no) |
AT (1) | ATE137243T1 (no) |
AU (1) | AU664096B2 (no) |
BR (1) | BR9302430A (no) |
CA (1) | CA2098875A1 (no) |
CZ (1) | CZ123193A3 (no) |
DE (1) | DE69302330T2 (no) |
DK (1) | DK0576230T3 (no) |
ES (1) | ES2087657T3 (no) |
FI (1) | FI932870A (no) |
GR (1) | GR3020064T3 (no) |
HU (1) | HUT64769A (no) |
IL (1) | IL106079A0 (no) |
MX (1) | MX9303711A (no) |
NO (1) | NO932289L (no) |
PL (1) | PL299414A1 (no) |
YU (1) | YU43193A (no) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5559222A (en) * | 1995-02-03 | 1996-09-24 | Eli Lilly And Company | Preparation of 1-(2'-deoxy-2',2'-difluoro-D-ribo-pentofuranosyl)-cytosine from 2-deoxy-2,2-difluoro-β-D-ribo-pentopyranose |
GB2321454A (en) * | 1997-01-24 | 1998-07-29 | Norsk Hydro As | Gemcitabine esters and amides |
GB9708611D0 (en) | 1997-04-28 | 1997-06-18 | Univ Cardiff | Chemical compounds |
US6326507B1 (en) | 1998-06-19 | 2001-12-04 | Trustees Of Dartmouth College | Therapeutic compounds and methods of use |
EP1229934B1 (en) | 1999-10-01 | 2014-03-05 | Immunogen, Inc. | Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
GB0009486D0 (en) | 2000-04-17 | 2000-06-07 | Univ Cardiff | Chemical compounds |
US7435755B2 (en) | 2000-11-28 | 2008-10-14 | The Trustees Of Dartmouth College | CDDO-compounds and combination therapies thereof |
WO2003059339A1 (en) | 2002-01-15 | 2003-07-24 | Trustees Of Dartmouth College | Tricyclic-bis-enone derivatives and methods of use thereof |
MXPA04007876A (es) * | 2002-02-14 | 2005-06-20 | Pharmasset Ltd | Analogos de nucleosido fluorado modificados. |
WO2004041203A2 (en) * | 2002-11-04 | 2004-05-21 | Xenoport, Inc. | Gemcitabine prodrugs, pharmaceutical compositions and uses thereof |
WO2004050678A2 (en) * | 2002-12-03 | 2004-06-17 | Baylor University | Compounds resistant to metabolic deactivation and methods of use |
US7214791B2 (en) * | 2004-07-01 | 2007-05-08 | Shenzhen Hande Technology Co., Ltd. | Method for preparation of 2′-deoxy-2′, 2′-difluoro-β-cytidine or pharmaceutically acceptable salts thereof by using 1,6-anhydro-β-d-glucose as raw material |
JP5022911B2 (ja) * | 2004-12-17 | 2012-09-12 | イーライ リリー アンド カンパニー | ゲムシタビンのアミドプロドラック、組成物、及びそれらの使用 |
NZ560735A (en) * | 2005-03-04 | 2009-07-31 | Dabur Pharma Ltd | Intermediate and process for preparing the beta-anomer of gemcitabine hydrochloride via a low temperature stereoselective glycosylation reaction |
CN1693309A (zh) * | 2005-04-18 | 2005-11-09 | 成都正开生物科技发展有限公司 | N4-(取代的氧羰基)-2′,2′-二氟-2′-脱氧胞苷衍生物及其应用 |
AT502635A1 (de) * | 2005-11-09 | 2007-05-15 | Saischek Und Partner Meg | Neue 1,3-dithioverbindungen, verfahren zu deren herstellung und ihre verwendung |
GB0609178D0 (en) | 2006-05-09 | 2006-06-21 | Univ Cardiff | Novel compounds |
EP2094651A1 (en) | 2006-11-17 | 2009-09-02 | Trustees Of Dartmouth College | Synthesis and biological activities of new tricyclic-bis-enones (tbes) |
US8921340B2 (en) | 2006-11-17 | 2014-12-30 | Trustees Of Dartmouth College | Methods for using synthetic triterpenoids in the treatment of bone or cartilage diseases or conditions |
US8299046B2 (en) | 2006-11-17 | 2012-10-30 | Trustees Of Dartmouth College | Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage growth |
TWI621624B (zh) | 2008-01-11 | 2018-04-21 | 瑞塔醫藥有限責任公司 | 合成的三萜系化合物及其使用於治療疾病之方法 |
CA2721665C (en) | 2008-04-18 | 2017-01-24 | Reata Pharmaceuticals, Inc. | Compounds including an anti-inflammatory pharmacore and methods of use |
MX2010011437A (es) | 2008-04-18 | 2010-12-20 | Reata Pharmaceuticals Inc | Moduladores antioxidantes de inflamacion: derivados del acido oleanolico con saturacion en el anillo c. |
KR20110010611A (ko) | 2008-04-18 | 2011-02-01 | 리타 파마슈티컬스 잉크. | 산화방지성 염증 조절제 c-17 일치된 올레아놀산 유도체 |
US8071632B2 (en) | 2008-04-18 | 2011-12-06 | Reata Pharmaceuticals, Inc. | Antioxidant inflammation modulators: novel derivatives of oleanolic acid |
DK2276493T3 (da) | 2008-04-18 | 2019-01-02 | Reata Pharmaceuticals Inc | Antioxidative inflammationsmodulatorer: oleanolsyrederivater med amino- og andre modifikationer ved c-17 |
DE102011077393A1 (de) * | 2011-06-10 | 2012-12-13 | Johannes Reinmüller | Antiinfektives Mittel |
WO2013151774A1 (en) | 2012-04-04 | 2013-10-10 | Halozyme, Inc. | Combination therapy with an anti - hyaluronan agent and a tumor - targeted taxane |
US8921419B2 (en) | 2012-05-08 | 2014-12-30 | Trustees Of Dartmouth College | Triterpenoids and compositions containing the same |
CA2889717A1 (en) * | 2012-10-29 | 2014-05-08 | Cocrystal Pharma, Inc. | Pyrimidine nucleotides and their monophosphate prodrugs for treatment of viral infections and cancer |
WO2016078160A1 (zh) * | 2014-11-17 | 2016-05-26 | 常州方圆制药有限公司 | 胞苷衍生物及其应用 |
WO2019222435A1 (en) | 2018-05-16 | 2019-11-21 | Halozyme, Inc. | Methods of selecting subjects for combination cancer therapy with a polymer-conjugated soluble ph20 |
GR1009958B (el) * | 2019-04-24 | 2021-03-18 | ΕΝΟΡΑΣΙΣ ΑΝΩΝΥΜΗ ΕΜΠΟΡΙΚΗ ΕΤΑΙΡΕΙΑ ΦΑΡΜΑΚΕΥΤΙΚΩΝ ΚΑΙ ΙΑΤΡΙΚΩΝ ΥΛΙΚΩΝ ΚΑΙ ΜΗΧΑΝΗΜΑΤΩΝ με δ.τ. "ΕΝΟΡΑΣΙΣ Α.Ε." | Παραγωγα γεμσιταβινης και μεθοδοι δημιουργιας παραγωγων γεμσιταβινης |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4526988A (en) * | 1983-03-10 | 1985-07-02 | Eli Lilly And Company | Difluoro antivirals and intermediate therefor |
ATE92499T1 (de) * | 1984-12-04 | 1993-08-15 | Lilly Co Eli | Tumorbehandlung bei saeugetieren. |
ZA859008B (en) * | 1984-12-04 | 1987-07-29 | Lilly Co Eli | The treatment of tumors in mammals |
CA1295998C (en) * | 1985-07-29 | 1992-02-18 | Sai P. Sunkara | Nucleosides and their use as antineoplastic agents |
DE3856477T2 (de) * | 1987-08-28 | 2001-11-08 | Lilly Co Eli | Verfahren zur Herstellung von 2'-deoxy-2',2'-difluornukleosiden |
US4965374A (en) * | 1987-08-28 | 1990-10-23 | Eli Lilly And Company | Process for and intermediates of 2',2'-difluoronucleosides |
US4914028A (en) * | 1988-02-10 | 1990-04-03 | Eli Lilly And Company | Method of preparing beta-2',2'-difluoronucleosides |
ES2075040T3 (es) * | 1988-02-16 | 1995-10-01 | Lilly Co Eli | 2',3'-dideoxi-2',2'-difluoronucleosidos. |
EP0339161A1 (en) * | 1988-04-01 | 1989-11-02 | Merrell Dow Pharmaceuticals Inc. | Novel fluorophosphonate nucleotide derivatives |
JPH0232093A (ja) * | 1988-06-08 | 1990-02-01 | Merrell Dow Pharmaceut Inc | 抗レトロウィルスジフルオロ化ヌクレオシド類 |
AU7558491A (en) * | 1990-04-04 | 1991-10-30 | Nycomed Imaging As | Nucleoside derivatives |
-
1992
- 1992-06-21 YU YU43193A patent/YU43193A/sh unknown
-
1993
- 1993-06-18 AU AU41348/93A patent/AU664096B2/en not_active Expired - Fee Related
- 1993-06-21 CA CA002098875A patent/CA2098875A1/en not_active Abandoned
- 1993-06-21 NO NO932289A patent/NO932289L/no unknown
- 1993-06-21 ES ES93304819T patent/ES2087657T3/es not_active Expired - Lifetime
- 1993-06-21 CN CN93107739A patent/CN1084177A/zh active Pending
- 1993-06-21 HU HU9301824A patent/HUT64769A/hu unknown
- 1993-06-21 JP JP5149170A patent/JPH0656876A/ja active Pending
- 1993-06-21 PL PL29941493A patent/PL299414A1/xx unknown
- 1993-06-21 EP EP93304819A patent/EP0576230B1/en not_active Expired - Lifetime
- 1993-06-21 DE DE69302330T patent/DE69302330T2/de not_active Expired - Fee Related
- 1993-06-21 KR KR1019930011311A patent/KR940005657A/ko not_active Application Discontinuation
- 1993-06-21 MX MX9303711A patent/MX9303711A/es unknown
- 1993-06-21 IL IL106079A patent/IL106079A0/xx unknown
- 1993-06-21 BR BR9302430A patent/BR9302430A/pt not_active Application Discontinuation
- 1993-06-21 FI FI932870A patent/FI932870A/fi not_active Application Discontinuation
- 1993-06-21 CZ CZ931231A patent/CZ123193A3/cs unknown
- 1993-06-21 DK DK93304819.1T patent/DK0576230T3/da active
- 1993-06-21 AT AT93304819T patent/ATE137243T1/de not_active IP Right Cessation
- 1993-10-29 US US08/146,368 patent/US5430026A/en not_active Expired - Fee Related
-
1996
- 1996-05-27 GR GR960401428T patent/GR3020064T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
FI932870A0 (fi) | 1993-06-21 |
CA2098875A1 (en) | 1993-12-23 |
EP0576230A1 (en) | 1993-12-29 |
EP0576230B1 (en) | 1996-04-24 |
DE69302330D1 (de) | 1996-05-30 |
DE69302330T2 (de) | 1996-10-10 |
AU664096B2 (en) | 1995-11-02 |
CN1084177A (zh) | 1994-03-23 |
IL106079A0 (en) | 1993-10-20 |
AU4134893A (en) | 1993-12-23 |
GR3020064T3 (en) | 1996-08-31 |
PL299414A1 (en) | 1993-12-27 |
ES2087657T3 (es) | 1996-07-16 |
BR9302430A (pt) | 1994-01-11 |
HU9301824D0 (en) | 1993-09-28 |
US5430026A (en) | 1995-07-04 |
FI932870A (fi) | 1993-12-23 |
MX9303711A (es) | 1994-05-31 |
ATE137243T1 (de) | 1996-05-15 |
JPH0656876A (ja) | 1994-03-01 |
KR940005657A (ko) | 1994-03-22 |
HUT64769A (en) | 1994-02-28 |
DK0576230T3 (da) | 1996-05-20 |
CZ123193A3 (en) | 1994-04-13 |
NO932289D0 (no) | 1993-06-21 |
YU43193A (sh) | 1997-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO932289L (no) | 2'-deoksy-2',2'-difluor(4-substituerte pyrimidin)nukleosider med antiviralog anticanceraktivitet og mellomprodukter | |
DE3854297D1 (de) | Nucleoside und nucleotide mit antiviraler, antitumoraler, antimetastatischer sowie immunstimulierender wirkung. | |
FI913236A0 (fi) | 9-purinylfosfonsyraderivat. | |
DE3650130D1 (de) | Antivirale Nukleoside. | |
DK0653439T3 (da) | Stabiliserede oligonukleotider og anvendelse heraf | |
ES480436A1 (es) | Un procedimiento para preparar un nucleosido o nucleotido dearabino furanosilo. | |
EP0576227A3 (en) | 2'-Deoxy-2',2'-difluoro(2,6,8-substituted) purine nucleosides having anti-viral and anti-cancer activity and intermediates | |
IE46107L (en) | Pyrimidine nucleosides | |
ES2083458T3 (es) | Composicion antivirica. | |
ATE131826T1 (de) | Anti-hiv pyrimidin nucleoside | |
DK0580753T3 (da) | Pyrimidinderivater til forøgelse af antitumoraktivitet | |
RU93046286A (ru) | 2'-дезокси-2', 2'-дифтор (4-замещенный пиримидин)нуклеозиды, обладающие противовирусной и противораковой активностью, промежуточные соединения и способ лечения | |
ATE98249T1 (de) | Phosphonoalkylpurin-derivate. | |
GB9506644D0 (en) | Preparation of nucleoside analogues | |
EP0353268A4 (en) | ANTI-TUMOR PURINES OF 6-SULFENAMIDE, 6-SULFINAMIDE AND 6-SULFONAMIDE, PURINE NUCLEOSIDES, PURINE NUCLEOTIDES AND RELATED COMPOUNDS. | |
ZA905616B (en) | Antiviral pyrimidine nucleosides | |
GB9218812D0 (en) | Further antiviral pyrimidine nucleosides | |
GB9318282D0 (en) | Further antiviral pyrimidine nucleosides |